Please provide your email address to receive an email when new articles are posted on . The FDA has approved an abbreviated new drug application for Alembic Pharmaceuticals’ tobramycin ophthalmic ...
A 10-year study of cultures obtained between 1994 and 2003 from patients with bacterial conjunctivitis found a threefold increase in resistance to ciprofloxacin for gram-positive pathogens (11.7% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results